None listed
Conditions
Interventions
Intervention1: Skin Pore Tightening Serum (PMS 127-089): Approximately 5-7 drops (0.5 to 0.6g) of the product to be applied evenly on entire face, each time, once in the morning after bath and once in
Sponsors
ITC Life Sciences Technology Centre
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participants in the age group of 19 to 50 years 2· Participants with enlarged skin pores, varied skin types including Sensitive skin 3· Participants willing to abide by the study protocol and refrain from using any product other than the provided Investigational product during the study course. 4· Participants with varied skin type i.e., normal, dry, oily, combination and sensitive skin in nearly equal ratio. 5· Participants willing to visit the site for periodic assessments on the scheduled dates. 6· Participants who exhibits good tolerance to the investigational product with no signs of sensitivity. 7· Participants who agree to refrain from any other test product during the study 8· Participants willing to give voluntary written informed consent and photography release. 9· Participants willing to abide by and comply with the study protocol. 10· Participants able to read and sign an appropriate informed consent form indicating their willingness to participate. 11· Participants willing and capable to follow the study rules and a fixed schedule.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women 2· Participants undergoing treatment for Seborrhoea, Acne, Dermatitis, skin lightening/ any other cosmetic/ dermatologic skin condition on face 3· Participants with pre-existing systemic disease requiring long-term medication (self-declaration) 4· Participants with genetic and endocrinal disorders [ self-disclosure] 5· Participants with drug induced acne [ self-disclosure] 6· Participants with any other signs of significant local irritation or skin disease. 7· Participants on oral hormonal treatment or oral medications (e.g., steroids, anti-oxidant) for eight weeks prior to the study which will compromise the study. 8· Participants who may change personal nutrition habits and other habits as per investigator’s discretion. 9· Participants who have participated in a similar investigation or any other clinical product evaluation test in the past four weeks 10· Participants under the influence of alcohol and/or drugs as well as addiction. 11· Participants with severe psychological illness or intellectual inability to understand the study. 12· Participants who have wounds, sunburn, scars, tattoos or piercings at the skin test sites. 13· Participants with uncontrolled disease (severe heart/circulatory, liver, kidney or lung disease, severe diabetes mellitus) or chronic infections (hepatitis, HIV) 14· Participants who have proven allergies against cosmetic ingredients or prior intolerance responses after applying cosmetic products.[ self-disclosure] 15· Participants who are taking antihistamines and/or medication to suppress the immune system (e.g., corticoids, cytostatics) and/or retinoids 16· Participants who might participate in any other clinical study during participation in the current study 17· Participants currently taking any medication, which the investigator believes may influence the interpretation of the data. 18· Participants having chronic or acute skin disease at the skin test sites within the last 14 days prior to the beginning of the study and/or during the study or had major surgery in the last year. 19· Participants undergoing any treatment of any active skin condition 20· Participants allergic or sensitive to bar cleansing products, creams/lotions, artificial jewellery or anything else. 21· Participants who are pregnant or nursing.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Reduction in the visibility of skin pores as per Dermatologist’s and / or Participants’ assessment 2· Reduction in the area, density, volume of facial skin pores as per objective assessment 3· Reduction in sebum as per instrumental measurements and Participants’ assessment 4· Reduction in comedones (Blackheads, Whiteheads)Timepoint: 4 weeks of product use | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in below mentioned skin parameters as per Dermatologist’s assessment, Participants assessment and Instrumental measurements · Texture · Epidermal turnover rate / Desquamation · Hydration/ Moisturization (Instant, Longevity and Deeper) · Firmness / Resilience · Radiance · Even tone · Clarity · Softness · SmoothnessTimepoint: 4 weeks of product use | — |
Countries
India
Contacts
Public ContactDr Mukesh Ramnane
MS Clinical Research Pvt Ltd
Outcome results
None listed